ARYx Therapeutics Inc
OTC:ARYX
ARYx Therapeutics Inc
OTC:ARYX
Price:
0.0005
USD
Market Cap:
$33.5
Income Statement
Earnings Waterfall
ARYx Therapeutics Inc
ARYx Therapeutics Inc
Income Statement
ARYx Therapeutics Inc
ARYx Therapeutics Inc
Currency: USD
| Jun-2007 | Sep-2007 | Dec-2007 | Mar-2008 | Jun-2008 | Sep-2008 | Dec-2008 | Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
1
|
1
|
0
|
2
|
2
|
2
|
0
|
2
|
2
|
2
|
0
|
2
|
2
|
2
|
|
| Revenue |
7
N/A
|
6
-10%
|
4
-33%
|
4
-2%
|
4
+3%
|
21
+393%
|
20
-5%
|
19
-5%
|
18
-6%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
5
N/A
|
4
-15%
|
4
+0%
|
4
0%
|
4
N/A
|
20
+427%
|
19
-5%
|
19
-5%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(27)
|
(29)
|
(33)
|
(37)
|
(41)
|
(47)
|
(50)
|
(49)
|
(45)
|
(38)
|
(31)
|
(28)
|
(22)
|
(17)
|
|
| Selling, General & Administrative |
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(10)
|
|
| Research & Development |
(20)
|
(21)
|
(25)
|
(28)
|
(31)
|
(37)
|
(40)
|
(39)
|
(35)
|
(29)
|
(21)
|
(16)
|
(11)
|
(7)
|
|
| Operating Income |
(23)
N/A
|
(25)
-10%
|
(29)
-16%
|
(33)
-14%
|
(37)
-14%
|
(26)
+29%
|
(30)
-15%
|
(30)
+1%
|
(27)
+9%
|
(38)
-40%
|
(31)
+19%
|
(28)
+11%
|
(22)
+20%
|
(17)
+25%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
1
|
1
|
1
|
1
|
1
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(21)
N/A
|
(24)
-11%
|
(28)
-16%
|
(32)
-16%
|
(37)
-15%
|
(26)
+29%
|
(31)
-19%
|
(32)
-1%
|
(29)
+8%
|
(40)
-39%
|
(33)
+18%
|
(30)
+10%
|
(24)
+19%
|
(18)
+24%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(21)
|
(24)
|
(28)
|
(32)
|
(37)
|
(26)
|
(31)
|
(32)
|
(29)
|
(40)
|
(33)
|
(30)
|
(24)
|
(18)
|
|
| Net Income (Common) |
(21)
N/A
|
(24)
-11%
|
(28)
-16%
|
(32)
-16%
|
(37)
-15%
|
(26)
+29%
|
(31)
-19%
|
(32)
-1%
|
(29)
+8%
|
(40)
-39%
|
(33)
+18%
|
(30)
+10%
|
(24)
+19%
|
(18)
+24%
|
|
| EPS (Diluted) |
-1.22
N/A
|
-20.52
-1 582%
|
-1.56
+92%
|
-1.81
-16%
|
-2.06
-14%
|
-1.41
+32%
|
-1.65
-17%
|
-1.15
+30%
|
-1.06
+8%
|
-1.47
-39%
|
-1.21
+18%
|
-1.01
+17%
|
-0.71
+30%
|
-0.54
+24%
|
|
Switch to:
Switch to:
See Also
Discover More
